Skip to main content
OpenTrials

Clinical trial condition

Diabetes

Explore clinical trials studying Diabetes. Study availability and eligibility vary by location and protocol.

2,489 public trials 175 recruiting studies
Refine in advanced search Browse all conditions

Diabetes trial results

Completed

The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes

NCT01617434

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Phoenix, Arizona, United States
  • Novo Nordisk Investigational Site Anaheim, California, United States
  • Novo Nordisk Investigational Site Fresno, California, United States
  • Novo Nordisk Investigational Site Los Angeles, California, United States
View all 86 locations
View Trial Details
Completed

The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus

NCT00700817

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Escondido, California, United States
  • Novo Nordisk Investigational Site Fresno, California, United States
  • Novo Nordisk Investigational Site Huntington Beach, California, United States
View all 166 locations
View Trial Details
Completed

Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes

NCT00614120

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
  • Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
  • Novo Nordisk Investigational Site Chongqing, Chongqing Municipality, China
  • Novo Nordisk Investigational Site Fuzhou, Fujian, China
View all 50 locations
View Trial Details
Completed

To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together

NCT00318461

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Ciudad Autonoma de Bs As, Argentina
  • Novo Nordisk Investigational Site Ciudad Autónoma de Bs As, Argentina
  • Novo Nordisk Investigational Site Ciudad Autónoma de BsAs, Argentina
  • Novo Nordisk Investigational Site Junín, Argentina
View all 190 locations
View Trial Details
Completed

A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin

NCT01570751

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Mesa, Arizona, United States
  • Novo Nordisk Investigational Site Fresno, California, United States
  • Novo Nordisk Investigational Site Greenbrae, California, United States
  • Novo Nordisk Investigational Site San Ramon, California, United States
View all 46 locations
View Trial Details
Completed

Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus

NCT01364428

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Huntsville, Alabama, United States
  • Novo Nordisk Investigational Site Goodyear, Arizona, United States
  • Novo Nordisk Investigational Site Mesa, Arizona, United States
  • Novo Nordisk Investigational Site Phoenix, Arizona, United States
View all 45 locations
View Trial Details
Completed

The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes

NCT01836523

Conditions
Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations
  • Novo Nordisk Investigational Site Little Rock, Arkansas, United States
  • Novo Nordisk Investigational Site Concord, California, United States
  • Novo Nordisk Investigational Site Encino, California, United States
  • Novo Nordisk Investigational Site Escondido, California, United States
View all 182 locations
View Trial Details
Completed

Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes

NCT01074268

Conditions
Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations
  • Novo Nordisk Investigational Site Caba, Argentina
  • Novo Nordisk Investigational Site Ciudad Autónoma de Bs As, Argentina
  • Novo Nordisk Investigational Site Mar del Plata, Argentina
  • Novo Nordisk Investigational Site Rosario, Argentina
View all 69 locations
View Trial Details

Related conditions